Total Visits

Views
Initial results of a clinical trial evaluating a full-length pegylated recombinant factor viii with extended half-life for the perioperative control of hemostasis in hemophilia A63

Select a period of time:

Views

Views
February 20253
March 202516
April 20252
May 20251
June 20251
July 202519
August 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
United States9
Brazil8
United Kingdom4
Spain1
Guatemala1
Mexico1
Senegal1
South Africa1
 

Top cities views

Views
São Paulo4
Campinas1
Council Bluffs1
Dakar1
Decatur1
Euclid1
Great Bend1
Guatemala City1
Houston1
Johannesburg1